Government
Scientists and physicians have been cautious about use of the drug for the disease, while President Trump touted it as a “game changer.”
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 30, 2020.
Here’s a look at the next two target action dates on the calendar for early April.
A summary of daily biopharma industry news. Please check out stories that are trending on March 27, 2020.
The NDA is for a new formulation of the drug as one-dose granules for oral suspension, would which largely be aimed at children and people who have difficulty swallowing.
Although Zeposia has now been approved in the United States, BMS said it was delaying commercialization due to the “unprecedented COVID-19 pandemic.”
A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.
The same day that New York Gov. Andrew Cuomo announced the initiation of a clinical trial using blood plasma from patients who have recovered from COVID-19, the U.S. Food and Drug Administration announced wider support for the practice.
PerkinElmer is the 16th company to receive an EUA for COVID-19 testing.
A summary of daily biopharma industry news. Please check out stories that are trending on March 25, 2020.
PRESS RELEASES